Primo Chemicals Reports Audited Financial Results FY26
Primo Chemicals Limited reported a consolidated net profit of Rs. 1537.08 lakh for FY26, up from Rs. 355.98 lakh in the previous year. Revenue from operations rose to Rs. 56169.23 lakh. The Board approved the audited financial results on May 5, 2026.

*this image is generated using AI for illustrative purposes only.
Primo Chemicals Limited has released its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the financial statements at its meeting held on May 5, 2026. The results have been prepared in accordance with the Indian Accounting Standards (Ind AS), and the company operates in a single business segment — Chemicals. The audit was conducted by M/s S. Tandon & Associates LLP, which issued an unmodified opinion on both the standalone and consolidated financial results.
Consolidated Financial Performance
On a consolidated basis, Primo Chemicals reported a net profit of Rs. 1537.08 lakh for FY26, a significant increase from Rs. 355.98 lakh in FY25. This includes the share of profit from its associate, M/s Flow Tech Chemicals (P) Limited, which amounted to Rs. 480.79 lakh for the year, compared to Rs. 120.77 lakh in the previous year. The company holds a 49% equity stake in this associate. Revenue from operations stood at Rs. 56169.23 lakh, up from Rs. 55555.81 lakh in FY25, while total revenue including other income was Rs. 58148.59 lakh. Profit before tax was Rs. 1682.14 lakh, and the basic and diluted earnings per equity share (EPS) for FY26 were Rs. 0.63, compared to Rs. 0.15 in FY25.
The company reported an exceptional item related to the statutory impact of the New Labour Codes, amounting to a provision of Rs. 19.55 lakh for the year. On November 21, 2025, the Government of India notified four Labour Codes, and the company assessed potential implications on employee benefit obligations accordingly.
Financial Highlights (Consolidated)
| Particulars: | FY26 (Rs. in Lakhs) | FY25 (Rs. in Lakhs) |
|---|---|---|
| Revenue from Operations: | 56169.23 | 55555.81 |
| Other Income: | 1979.36 | 2088.87 |
| Total Revenue: | 58148.59 | 57644.68 |
| Total Expenses: | 56446.90 | 56133.15 |
| Profit Before Tax: | 1682.14 | 1511.53 |
| Share of Profit of Associates: | 480.79 | 120.77 |
| Net Profit: | 1537.08 | 355.98 |
| EPS (Basic & Diluted): | 0.63 | 0.15 |
Standalone Financial Results
On a standalone basis, Primo Chemicals reported a profit after tax (PAT) of Rs. 1056.29 lakh for FY26, compared to Rs. 235.21 lakh in FY25. Revenue from operations on a standalone basis was Rs. 56169.23 lakh, matching the consolidated figures. Total expenses for the year stood at Rs. 56446.90 lakh. The standalone basic and diluted EPS for FY26 was Rs. 0.44, up from Rs. 0.10 in the prior year. The paid-up equity share capital remained constant at Rs. 4846.86 lakh, with a face value of Rs. 2.00 per share.
Standalone Financial Highlights
| Particulars: | FY26 (Rs. in Lakhs) | FY25 (Rs. in Lakhs) |
|---|---|---|
| Revenue from Operations: | 56169.23 | 55555.81 |
| Total Revenue: | 58148.59 | 57644.68 |
| Total Expenses: | 56446.90 | 56133.15 |
| Profit Before Tax: | 1682.14 | 1511.53 |
| Profit After Tax: | 1056.29 | 235.21 |
| EPS (Basic & Diluted): | 0.44 | 0.10 |
Assets and Liabilities
On a consolidated basis, total assets stood at Rs. 69248.36 lakh as of March 31, 2026, compared to Rs. 74054.43 lakh in the previous year. Non-current assets were Rs. 58444.94 lakh, while current assets totalled Rs. 10803.42 lakh. Equity share capital remained unchanged at Rs. 4846.86 lakh, with other equity at Rs. 35769.67 lakh. Non-current liabilities decreased to Rs. 9268.38 lakh from Rs. 11193.06 lakh, and current liabilities reduced to Rs. 19363.45 lakh from Rs. 23789.97 lakh. On a standalone basis, total assets were Rs. 68003.19 lakh, down from Rs. 73290.05 lakh in the prior year.
Consolidated Assets & Liabilities Summary
| Particulars: | FY26 (Rs. in Lakhs) | FY25 (Rs. in Lakhs) |
|---|---|---|
| Total Assets: | 69248.36 | 74054.43 |
| Non-Current Assets: | 58444.94 | 59578.12 |
| Current Assets: | 10803.42 | 14476.31 |
| Equity Share Capital: | 4846.86 | 4846.86 |
| Other Equity: | 35769.67 | 34224.54 |
| Non-Current Liabilities: | 9268.38 | 11193.06 |
| Current Liabilities: | 19363.45 | 23789.97 |
Cash Flow Statement
The net cash generated from operating activities for FY26 was Rs. 6468.33 lakh, compared to Rs. 6443.35 lakh in the previous year. Cash used in investing activities amounted to Rs. 1781.59 lakh, primarily on account of the purchase of fixed assets worth Rs. 2601.58 lakh. Financing activities resulted in a net outflow of Rs. 4601.55 lakh, driven by repayment of term loans to banks amounting to Rs. 7001.27 lakh. Consequently, the company reported a net increase in cash and cash equivalents of Rs. 85.19 lakh, bringing the closing balance to Rs. 101.95 lakh from Rs. 16.76 lakh at the beginning of the year.
Cash Flow Summary (Consolidated)
| Particulars: | FY26 (Rs. in Lakhs) | FY25 (Rs. in Lakhs) |
|---|---|---|
| Net Cash from Operating Activities: | 6468.33 | 6443.35 |
| Net Cash Used in Investing Activities: | (1781.59) | (4297.89) |
| Net Cash from Financing Activities: | (4601.55) | (2175.83) |
| Net Increase/(Decrease) in Cash: | 85.19 | (30.37) |
| Closing Cash & Cash Equivalents: | 101.95 | 16.76 |
Historical Stock Returns for Primo Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.32% | +9.91% | +12.83% | +11.32% | +2.87% | -10.34% |
Given Primo Chemicals' significant improvement in net profit (from Rs. 355.98 lakh to Rs. 1537.08 lakh), what strategic investments or capacity expansions is the company planning to pursue in FY27 to sustain this growth momentum?
With Flow Tech Chemicals contributing Rs. 480.79 lakh in associate profits — nearly 4x the prior year — is Primo Chemicals considering increasing its 49% equity stake to gain greater control over this high-performing associate?
As the company aggressively repaid Rs. 7001.27 lakh in term loans during FY26, how will the resulting reduction in debt obligations impact its capital allocation strategy and potential dividend payouts going forward?


































